X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2682) 2682
Publication (170) 170
Book Review (23) 23
Book Chapter (7) 7
Conference Proceeding (7) 7
Magazine Article (7) 7
Book / eBook (4) 4
Dissertation (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1626) 1626
animals (1078) 1078
male (978) 978
female (875) 875
phosphatidylcholines - therapeutic use (835) 835
index medicus (830) 830
pharmacology & pharmacy (598) 598
phosphatidylcholine (482) 482
middle aged (481) 481
adult (457) 457
phosphatidylcholines - chemistry (385) 385
rats (381) 381
mice (356) 356
liposomes (334) 334
lipids (319) 319
aged (295) 295
phosphatidylcholines - metabolism (287) 287
phospholipids (232) 232
drug combinations (229) 229
biochemistry & molecular biology (221) 221
cholesterol (217) 217
phosphatidylcholines - administration & dosage (213) 213
lecithin (196) 196
phosphatidylcholines (186) 186
metabolism (182) 182
phosphatidylcholines - pharmacology (177) 177
liposomes - chemistry (172) 172
particle size (162) 162
research (158) 158
amphotericin b - therapeutic use (148) 148
phosphatidylglycerols - therapeutic use (147) 147
cholesterol - blood (135) 135
adolescent (133) 133
analysis (132) 132
antifungal agents - therapeutic use (132) 132
multidisciplinary sciences (132) 132
drug delivery systems (128) 128
infant, newborn (127) 127
phosphatidylcholines - analysis (123) 123
time factors (122) 122
treatment outcome (121) 121
article (120) 120
physiological aspects (119) 119
medicine (116) 116
pregnancy (116) 116
in-vitro (112) 112
cancer (111) 111
disease models, animal (111) 111
double-blind method (111) 111
rabbits (111) 111
health aspects (109) 109
research article (109) 109
phosphatidylcholines - blood (107) 107
liver - metabolism (106) 106
chemistry, multidisciplinary (104) 104
cells (103) 103
drug therapy, combination (102) 102
cholesterol - chemistry (101) 101
rats, sprague-dawley (101) 101
lipid metabolism (100) 100
rats, wistar (99) 99
care and treatment (97) 97
proteins (95) 95
solubility (93) 93
clinical trials as topic (91) 91
lipids - blood (91) 91
choline (90) 90
drugs (90) 90
oxidative stress (90) 90
cell line, tumor (88) 88
cell biology (87) 87
phospholipids - metabolism (87) 87
chemistry, medicinal (86) 86
microbiology (86) 86
administration, oral (84) 84
inflammation (84) 84
kinetics (84) 84
triglycerides - blood (84) 84
atherosclerosis (83) 83
cholesterol - metabolism (83) 83
nanoparticles (83) 83
permeability (81) 81
drug stability (80) 80
oncology (80) 80
phosphatidylcholines - adverse effects (80) 80
membranes (78) 78
immunology (77) 77
in vitro techniques (77) 77
therapy (77) 77
science (76) 76
child (75) 75
liver (75) 75
liver - drug effects (75) 75
pharmacokinetics (75) 75
diet (74) 74
dose-response relationship, drug (74) 74
drug carriers (74) 74
infectious diseases (74) 74
phosphatidylcholine-sterol o-acyltransferase - blood (74) 74
alzheimer disease - drug therapy (73) 73
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2339) 2339
Russian (152) 152
German (57) 57
Italian (50) 50
French (21) 21
Japanese (21) 21
Czech (12) 12
Ukrainian (9) 9
Chinese (8) 8
Spanish (7) 7
Polish (6) 6
Slovak (5) 5
Dutch (3) 3
Portuguese (3) 3
Danish (2) 2
Hebrew (2) 2
Romanian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Veterinary Clinics of North America - Small Animal Practice, ISSN 0195-5616, 05/2009, Volume 39, Issue 3, pp. 631 - 652
Many medicinal, nutraceutical, and botanic extracts have been used as cytoprotective agents in liver disease. This article explains the mechanisms of action,... 
Silymarin | Ursodeoxycholate | Vitamin E | S-adenosylmethionine | Glutathione | N-acetylcysteine | CHOLESTATIC LIVER-DISEASES | VITAMIN-E | SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX | ISCHEMIA-REPERFUSION INJURY | ADENOSYL-L-METHIONINE | URSODEOXYCHOLIC ACID | PRIMARY BILIARY-CIRRHOSIS | VETERINARY SCIENCES | PRIMARY RAT HEPATOCYTES | Free Radical Scavengers - pharmacology | Cholagogues and Choleretics - pharmacology | Cat Diseases - drug therapy | Cryoprotective Agents - therapeutic use | Biliary Tract Diseases - veterinary | Cholagogues and Choleretics - therapeutic use | Ursodeoxycholic Acid - therapeutic use | Cat Diseases - prevention & control | Cryoprotective Agents - pharmacology | Dog Diseases - drug therapy | Vitamin E - therapeutic use | Free Radical Scavengers - therapeutic use | Silymarin - pharmacology | Acetylcysteine - therapeutic use | Dog Diseases - prevention & control | Silymarin - therapeutic use | Cats | Liver Diseases - prevention & control | Antioxidants - pharmacology | Liver Diseases - veterinary | S-Adenosylmethionine - pharmacology | Biliary Tract Diseases - drug therapy | Biliary Tract Diseases - prevention & control | Ursodeoxycholic Acid - pharmacology | Antioxidants - therapeutic use | Animals | S-Adenosylmethionine - therapeutic use | Acetylcysteine - pharmacology | Dogs | Liver Diseases - drug therapy | Vitamin E - pharmacology
Journal Article
Nature Reviews Drug Discovery, ISSN 1474-1776, 2014, Volume 13, Issue 6, pp. 445 - 464
Since the discovery in the 1970s that plasma levels of high-density lipoprotein cholesterol (HDL-C) are inversely associated with cardiovascular outcome, it... 
CHOLESTERYL-ESTER-TRANSFER | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ANTISENSE OLIGONUCLEOTIDE INHIBITION | TRANSFER PROTEIN CETP | PHARMACOLOGY & PHARMACY | RESTORES ENDOTHELIAL FUNCTION | APOA-I | CORONARY-HEART-DISEASE | PRE-BETA | HIGH-DENSITY-LIPOPROTEIN | APOLIPOPROTEIN-A-I | ARTERY-DISEASE | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Recombinant Proteins - therapeutic use | Drugs, Investigational - adverse effects | Lipoproteins, HDL - agonists | Hypolipidemic Agents - metabolism | Lipoproteins, HDL - blood | Cardiovascular Diseases - prevention & control | Humans | Lipoproteins, HDL - metabolism | Drugs, Investigational - therapeutic use | Drugs, Investigational - metabolism | Recombinant Proteins - adverse effects | Phosphatidylcholine-Sterol O-Acyltransferase - genetics | Apolipoprotein A-I - genetics | Niacin - therapeutic use | Cardiovascular Diseases - blood | Lipoproteins, HDL - therapeutic use | Niacin - adverse effects | Recombinant Proteins - metabolism | Hypolipidemic Agents - adverse effects | Molecular Targeted Therapy - adverse effects | Cardiovascular Diseases - metabolism | Clinical Trials as Topic | Apolipoprotein A-I - metabolism | Apolipoprotein A-I - agonists | Niacin - metabolism | Up-Regulation - drug effects | Phosphatidylcholine-Sterol O-Acyltransferase - adverse effects | Animals | Models, Biological | Phosphatidylcholine-Sterol O-Acyltransferase - therapeutic use | Hypolipidemic Agents - therapeutic use | Cholesterol Ester Transfer Proteins - metabolism | Phosphatidylcholine-Sterol O-Acyltransferase - metabolism | Care and treatment | High density lipoproteins | Patient outcomes | Development and progression | Research | Cardiovascular diseases | Risk factors
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 05/2012, Volume 52, Issue 9, pp. 1658 - 1665
Journal Article
Journal Article
Cancer Discovery, ISSN 2159-8274, 11/2013, Volume 3, Issue 11, pp. 1302 - 1315
Journal Article
Journal Article
Journal Article